SARS-CoV-2 Variants - Coronavirus COVID-19 **NO DISCUSSION**

  • #221
  • #222
  • #223

Statement on the antigen composition of COVID-19 vaccines​

26 April 2024

  • “SARS-CoV-2 continues to circulate and evolve with important genetic and antigenic evolution of the spike protein.

  • The objective of an update to COVID-19 vaccine antigen composition is to enhance vaccine-induced immune responses to circulating SARS-CoV-2 variants.

  • As the virus is expected to continue to evolve from JN.1, the TAG-CO-VAC advises the use of a monovalent JN.1 lineage as the antigen in future formulations of COVID-19 vaccines.

  • In accordance with WHO SAGE policy, vaccination programmes should continue to use any of the WHO emergency-use listed or prequalified COVID-19 vaccines and vaccination should not be delayed in anticipation of access to vaccines with an updated composition.”


* more at link
 
  • #224

Guardians Monthly Goal

Staff online

Members online

Online statistics

Members online
86
Guests online
1,848
Total visitors
1,934

Forum statistics

Threads
636,175
Messages
18,691,830
Members
243,538
Latest member
SuneDK
Back
Top